• All Courts
  • Federal Courts
  • Bankruptcies
  • PTAB
  • ITC
Track Search
Export
Download All
Displaying 24-38 of 129 results

2005 Exhibit: Braccos Opening Markman Brief

Document IPR2019-00345, No. 2005 Exhibit - Braccos Opening Markman Brief (P.T.A.B. Mar. 4, 2019)

cite Cite Document

2001 Exhibit: Amended Joint Claim Construction and Prehearing Statement

Document IPR2019-00345, No. 2001 Exhibit - Amended Joint Claim Construction and Prehearing Statement (P.T.A.B. Mar. 4, 2019)

cite Cite Document

2004 Exhibit: Braccos Responses to Invalidity Contentions

Document IPR2019-00345, No. 2004 Exhibit - Braccos Responses to Invalidity Contentions (P.T.A.B. Mar. 4, 2019)

cite Cite Document

1008 Exhibit: Bacarese Hamilton et al, Prevention of Cholecystokinin Oxidation Dur...

Document IPR2019-00345, No. 1008-8 Exhibit - Bacarese Hamilton et al, Prevention of Cholecystokinin Oxidation During Tissue Extraction, 448 Neuronal Cholecystokinin 571 1985 (P.T.A.B. Nov. 19, 2018...

cite Cite Document

1010 Exhibit: US Patent No 7,329,644 to Saviano et al

Document IPR2019-00345, No. 1010-10 Exhibit - US Patent No 7,329,644 to Saviano et al (P.T.A.B. Nov. 19, 2018)

cite Cite Document

1046 Exhibit: US Patent No 6,238,664 to Hellerbrand et al

Document IPR2019-00345, No. 1046-46 Exhibit - US Patent No 6,238,664 to Hellerbrand et al (P.T.A.B. Nov. 19, 2018)

cite Cite Document

1001 Exhibit: US Patent No 6,803,046 to Metcalfe et al

Document IPR2019-00345, No. 1001 Exhibit - US Patent No 6,803,046 to Metcalfe et al (P.T.A.B. Nov. 19, 2018)

cite Cite Document

1009 Exhibit: Bacarese Hamilton et al, OxidationReduction of Methionine Residues...

Document IPR2019-00345, No. 1009-9 Exhibit - Bacarese Hamilton et al, OxidationReduction of Methionine Residues in CCK A Study by Radioimmunoassay and Isocratic Reverse Phase High Pressure Liq...

cite Cite Document

1020 Exhibit: Wunsch, E, Peptide Factors as Pharmaceuticals Criteria for Applicatio...

Document IPR2019-00345, No. 1020-20 Exhibit - Wunsch, E, Peptide Factors as Pharmaceuticals Criteria for Application, 22 Biopolymers 493 1983 (P.T.A.B. Nov. 19, 2018)

cite Cite Document

1041 Exhibit: Bush et al, A critical evaluation of clinical trials in reactions to sulfites,...

Document IPR2019-00345, No. 1041-41 Exhibit - Bush et al, A critical evaluation of clinical trials in reactions to sulfites, 78 J Allergy Clin Immunol 191 1986 (P.T.A.B. Nov. 19, 2018)

cite Cite Document

1037 Exhibit: Jensen et al, Metal Catalyzed Oxidation of Brain Derived Neurotrophi...

Document IPR2019-00345, No. 1037-37 Exhibit - Jensen et al, Metal Catalyzed Oxidation of Brain Derived Neurotrophic Factor BDNF Selectivity and Conformational Consequences of Histidine Modification...

cite Cite Document

1025 Exhibit: Marseigne, et al, Full Agonists of CCK8 Containing a Nonhydrolyzable...

Document IPR2019-00345, No. 1025-25 Exhibit - Marseigne, et al, Full Agonists of CCK8 Containing a Nonhydrolyzable Sulfated Tyrosine Residue, 32 J Med Chem 445 1989 (P.T.A.B. Nov. 19, 2018)

cite Cite Document

1038 Exhibit: Swadesh, et al, Sodium Sulfite as an Antioxidant in the Acid Hydrolys...

Document IPR2019-00345, No. 1038-38 Exhibit - Swadesh, et al, Sodium Sulfite as an Antioxidant in the Acid Hydrolysis of Bovine Pancreatic Ribonuclease A, 141 Analytical Biochemistry 397 1984 (P.T.A....

cite Cite Document

1027 Exhibit: Liddle, R A, Cholecystokinin Cells, 59 Annu Rev Physiol 221 1997

Document IPR2019-00345, No. 1027-27 Exhibit - Liddle, R A, Cholecystokinin Cells, 59 Annu Rev Physiol 221 1997 (P.T.A.B. Nov. 19, 2018)

cite Cite Document

1043 Exhibit: Konturek, et al, Effect of Cholecystokinin Receptor Antagonist on Pan...

Document IPR2019-00345, No. 1043-43 Exhibit - Konturek, et al, Effect of Cholecystokinin Receptor Antagonist on Pancreatic Responses 1988 (P.T.A.B. Nov. 19, 2018)

cite Cite Document
<< 1 2 3 4 5 6 ... 8 9 10 >>